Anti-aging drug for dogs moves closer to gaining FDA approval

An experimental anti-aging drug aimed at extending the lifespans of large-breed dogs is moving through the FDA process, prompting debate over ethics, regulation, and how much society should invest in companion-animal medicine. Commenters weigh evolutionary explanations for programmed aging, the tradeoffs of selectively breeding dogs, and parallels to emerging human longevity treatments. The thread also branches into practical pet-care topics such as arthritis therapies like Librela/Solensia, diet and hydration for cats, and concerns about dog welfare in urban environments and breed health.

Biology and “programmed” aging

  • Some discuss why animals would have hormones that accelerate aging instead of just “wearing out.”
  • Proposed explanations: aging pathways are side effects of growth/healing hormones like IGF‑1; high growth hormone is advantageous for large predators but shortens lifespan.
  • Natural selection optimizes replication, not individual health; faster turnover can be adaptive in scarce environments.
  • Examples like octopus “programmed death” after reproduction are cited as precedent for hormonally triggered aging.

Media source and primary information

  • Several dislike Fox News as a source, calling it untrustworthy, but note that for low‑stakes, nonpolitical science news it may be fine.
  • Others share the company’s press release and alternate news links.

Anti‑arthritis biologics (Librela/Solensia)

  • Many report strong positive experiences with Librela for dogs and Solensia for cats: rapid pain relief, restored mobility, and perceived “extra time” with older pets.
  • A few describe more modest improvements, cautioning against calling it a miracle.
  • Typical reported costs are around $80–$100/month, varying by country and pet size.
  • These are framed as arthritis pain treatments, not life‑extension per se.

Regulation of veterinary drugs

  • One side argues FDA resources shouldn’t be “wasted” on pet drugs; market forces and safety‑only rules should suffice.
  • Others counter that:
    • People spend heavily on pets and need protection from snake oil, especially for life‑extension claims.
    • Rigorous trials are essential to measure lifespan effects; without regulation, companies lack incentive to run them.
    • FDA oversight also protects the food chain and ecosystems.
  • Some doubt that dropping animal regulation would meaningfully speed human drug approvals.

Extending pet lifespans vs accepting death

  • Some view canine life‑extension and “transanimalism” as resisting the natural passage of time and grief.
  • Others respond that dogs die far too early, and improving longevity is a compassionate, legitimate scientific goal.
  • Debate touches on broader human life‑extension; some see indefinite lifespan as inevitable, others as unproven wishful thinking.

Breeds, size, and health

  • Multiple commenters advocate for mixed‑breed dogs and cats as generally healthier than inbred purebreds.
  • Discussion notes extreme artificial selection in dogs (e.g., brachycephalic breeds, giant breeds) and associated health and lifespan trade‑offs.
  • Some question the point of making giant dogs live longer instead of choosing healthier, medium‑sized breeds; others emphasize the unique temperament and family value of giant breeds.

Pit bull safety debate

  • One cluster warns strongly against pit bulls and mixes, citing personal experiences and studies showing overrepresentation in severe/fatal attacks.
  • Critics argue “pit bull” is a vague category, many statistics are methodologically weak, and socio‑economic factors and training/socialization are more important than genetics alone.
  • Some maintain that any large, powerful breed can be dangerous; others insist pit‑type dogs are uniquely risky.

Cat longevity and care tips

  • Thread on cat “anti‑aging” focuses on fundamentals rather than drugs: high‑meat diets, avoiding or limiting dry food, ensuring hydration, indoor‑only living, and environmental enrichment.
  • Some recommend raw or high‑meat wet food for issues like IBD and urinary health, reporting substantial improvements.
  • There is debate over dry food’s dental benefits; several argue it’s overstated and prefer tooth‑brushing or chewy/raw foods.
  • Indoor vs outdoor and single vs multiple cats are discussed:
    • Indoor life is defended as safer and low‑stress if owners provide play, toys, and window views.
    • Others worry about restricted “freedom” and suggest multiple indoor cats where owners are often away.

Big dogs in urban environments

  • One commenter is disturbed by large, high‑energy dogs kept in small city apartments, calling it near‑torture if they lack space and proper exercise.
  • Others note that well‑exercised city dogs can be fine, but acknowledge it’s harder to meet their needs in dense urban settings.

Company participation and miscellany

  • The startup’s founder briefly appears in the thread, describing the FDA milestone as a significant step for both dogs and lifespan‑extension pharma.
  • A few note the irony/humor of Fox covering a dog‑related story.